Log in
Enquire now
‌

US Patent 8980822 Therapeutic agent preparations comprising pramlintide for delivery into a lumen of the intestinal tract using a swallowable drug delivery device

Patent 8980822 was granted and assigned to Rani Therapeutics on March, 2015 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Current Assignee
Rani Therapeutics
Rani Therapeutics
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
89808220
Patent Inventor Names
Mir Imran0
Date of Patent
March 17, 2015
0
Patent Application Number
135387830
Date Filed
June 29, 2012
0
Patent Citations Received
‌
US Patent 12064520 Components with high API loading
0
‌
US Patent 11833319 Propulsive drug delivery from a swallowable device into a patients intestinal tract
0
‌
US Patent 11872396 Swallowable capsule and method for stimulating incretin production within the intestinal tract
0
‌
US Patent 12018090 PCSK9 antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
0
‌
US Patent 12059562 Systems for electrical stimulation
0
‌
US Patent 11712421 Self-actuating articles
0
‌
US Patent 11771829 Systems and methods for liquid injection
‌
US Patent 11771879 Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
Patent Primary Examiner
‌
Gyan Chandra
0
Patent abstract

Embodiments of the invention provide swallowable devices, preparations and methods for delivering drugs and other therapeutic agents within the GI tract. Many embodiments provide a swallowable device for delivering the agents. Particular embodiments provide a swallowable device such as a capsule for delivering drugs into the intestinal wall or other GI lumen. Embodiments also provide various drug preparations that are configured to be contained within the capsule, advanced from the capsule into the intestinal wall and degrade to release the drug into the bloodstream to produce a therapeutic effect. The preparation can be operably coupled to delivery means having a first configuration where the preparation is contained in the capsule and a second configuration where the preparation is advanced out of the capsule into the intestinal wall. Embodiments of the invention are particularly useful for the delivery of drugs which are poorly absorbed, tolerated and/or degraded within the GI tract.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 8980822 Therapeutic agent preparations comprising pramlintide for delivery into a lumen of the intestinal tract using a swallowable drug delivery device

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.